Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei).

Abigail I WaldJames F PingpankMelanie OngchinLauren B HallHeather JonesShannon AltpeterMichelle LiebdzinskiAhmed B HamedJoshua DerbyMarina N NikiforovaPhoenix D BellAlessandro PanicciaAmer H ZureikatVikram C GorantlaJohn C RheeRoby ThomasDavid L BartlettKatelyn SmithPatrick HennBrian K TheisenSusan ShyuAkram ShalabyM Haroon A ChoudryAatur D Singhi

Published in: Annals of surgical oncology (2023)

Targeted NGS improves the prognostic assessment of patients with disseminated AMNs and identifies patients who may require increased surveillance and/or aggressive management.

Keyphrases

low grade
cancer therapy
public health
genome wide
copy number
high grade
drug delivery
dna methylation
gene expression
clinical evaluation